441 related articles for article (PubMed ID: 24037629)
1. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
2. Chronic thromboembolic pulmonary hypertension.
Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
[TBL] [Abstract][Full Text] [Related]
3. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
Hill NS; Preston IR; Roberts KE
Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
[No Abstract] [Full Text] [Related]
4. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Mielniczuk LM; Swiston JR; Mehta S
Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
[TBL] [Abstract][Full Text] [Related]
5. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
[TBL] [Abstract][Full Text] [Related]
7. [Chronic thromboembolic pulmonary hypertension: diagnosis, medical therapy and monitoring].
Gölbaşi Z
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():56-60. PubMed ID: 20819758
[TBL] [Abstract][Full Text] [Related]
8. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
9. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.
Bresser P; Pepke-Zaba J; Jaïs X; Humbert M; Hoeper MM
Proc Am Thorac Soc; 2006 Sep; 3(7):594-600. PubMed ID: 16963540
[TBL] [Abstract][Full Text] [Related]
10. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
11. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.
Pepke-Zaba J; Jais X; Channick R
Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.
Tanabe N; Sugiura T; Tatsumi K
Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639
[TBL] [Abstract][Full Text] [Related]
13. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension.
Claessen G; La Gerche A; Wielandts JY; Bogaert J; Van Cleemput J; Wuyts W; Claus P; Delcroix M; Heidbuchel H
Heart; 2015 Apr; 101(8):637-44. PubMed ID: 25686630
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term efficacy and safety of sildenafil for the treatment of chronic thromboembolic pulmonary hypertension in a heart transplant recipient.
Zacà V; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
Pharmacology; 2011; 87(1-2):24-7. PubMed ID: 21178386
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary arterial hypertension following pulmonary thromboembolism].
Wilkens H
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S328-9. PubMed ID: 17139599
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
[TBL] [Abstract][Full Text] [Related]
17. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension.
Hoeper MM
Eur Respir Rev; 2015 Jun; 24(136):272-82. PubMed ID: 26028639
[TBL] [Abstract][Full Text] [Related]
19. Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension.
Hadinnapola C; Pepke-Zaba J
Expert Rev Respir Med; 2015 Oct; 9(5):559-69. PubMed ID: 26366805
[TBL] [Abstract][Full Text] [Related]
20. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
Garnock-Jones KP
Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
